Stay updated on Phase II Anti-PD1 Epigenetic Therapy Clinical Trial

Sign up to get notified when there's something new on the Phase II Anti-PD1 Epigenetic Therapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase II Anti-PD1 Epigenetic Therapy Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2 on the page.
    Difference
    0.0%
    Check dated 2026-04-16T10:45:08.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    42 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and Revision: v3.4.3 was removed.
    Difference
    0.0%
    Check dated 2026-03-18T15:41:35.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. This appears to be a site version update with no changes to study data or participant information.
    Difference
    0.0%
    Check dated 2026-03-11T16:09:47.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed Revision: v3.4.1 and the lapse in government funding notice.
    Difference
    0.4%
    Check dated 2026-02-11T02:05:10.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and a status update for the NIH Clinical Center; introduced revision tag v3.4.1 and removed v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-03T23:46:33.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    The page now displays a glossary option and updates the footer with QC-related metadata (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-27T23:55:11.000Z thumbnail image

Stay in the know with updates to Phase II Anti-PD1 Epigenetic Therapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase II Anti-PD1 Epigenetic Therapy Clinical Trial page.